Shine Investment Advisory Services’s Takeda Pharmaceutical TAK Stock Holding History

Shine Investment Advisory Services’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$18K	Hold	1,004	–	–	0.01%	463
2020 Q2	$18K	Hold	1,004	–	–	0.01%	468
2020 Q1	$15K	Sell	1,004 -36	-3%	-$652	0.01%	466
2019 Q4	$21K	Hold	1,040	–	–	0.01%	470
2019 Q3	$18K	Sell	1,040 -337	-24%	-$5.83K	0.01%	473
2019 Q2	$24K	Hold	1,377	–	–	0.01%	433
2019 Q1	$28K	Buy	+1,377	New	+$27.7K	0.01%	421

Other funds holding TAK

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Shine Investment Advisory Services's TAK Position: Q3 2020 in Review

Shine Investment Advisory Services held its Takeda Pharmaceutical (TAK) position steady in Q3 2020 at 1,004 shares worth $18K. The position accounts for 0.01% of the portfolio, ranked #463.

Shine Investment Advisory Services first reported a position in TAK in Q1 2019 and has held it in 7 quarters since. The position peaked at $28K in Q1 2019. 311 funds tracked by Wall St. Rank hold TAK as of Q3 2020.

Shine Investment Advisory Services held 1,004 shares of Takeda Pharmaceutical worth $18K as of Q3 2020.
Shine Investment Advisory Services left its Takeda Pharmaceutical share count unchanged in Q3 2020.
Takeda Pharmaceutical made up 0.01% of Shine Investment Advisory Services's portfolio in Q3 2020, its #463 holding.
Shine Investment Advisory Services first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 7 quarters since.
Shine Investment Advisory Services's Takeda Pharmaceutical position peaked at $28K in Q1 2019.
311 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.